BIOMAT Database Logo BIOMAT Database Logo

Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study. 1987

E J Tilchen, and T Fleming, and G Mills, and N Oishi, and J D Bonnett, and R B Natale, and G Harker, and C A Coltman
Henry Ford Hospital, Detroit, MI.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001388 Aziridines Saturated azacyclopropane compounds. They include compounds with substitutions on CARBON or NITROGEN atoms. Ethyleneimines,Azacyclopropanes, Saturated,Dimethyleneimines,Saturated Azacyclopropanes

Related Publications

E J Tilchen, and T Fleming, and G Mills, and N Oishi, and J D Bonnett, and R B Natale, and G Harker, and C A Coltman
Phase II study of diaziquone in untreated advanced gastric carcinoma. A Southwest Oncology Group Study.
February 1989, American journal of clinical oncology,
E J Tilchen, and T Fleming, and G Mills, and N Oishi, and J D Bonnett, and R B Natale, and G Harker, and C A Coltman
Phase II evaluation of mitoxantrone in advanced pancreatic carcinoma: a Southwest Oncology Group study.
February 1990, Investigational new drugs,
E J Tilchen, and T Fleming, and G Mills, and N Oishi, and J D Bonnett, and R B Natale, and G Harker, and C A Coltman
Phase II trial of amsacrine in pancreatic carcinoma: a Southwest Oncology Group study.
November 1984, Cancer treatment reports,
E J Tilchen, and T Fleming, and G Mills, and N Oishi, and J D Bonnett, and R B Natale, and G Harker, and C A Coltman
Phase II trial of merbarone in pancreatic carcinoma. A Southwest Oncology Group study.
August 1993, American journal of clinical oncology,
E J Tilchen, and T Fleming, and G Mills, and N Oishi, and J D Bonnett, and R B Natale, and G Harker, and C A Coltman
Phase II study of diaziquone in advanced soft tissue and bony sarcoma: a Southwest Oncology Group study.
September 1985, Cancer treatment reports,
E J Tilchen, and T Fleming, and G Mills, and N Oishi, and J D Bonnett, and R B Natale, and G Harker, and C A Coltman
Phase II evaluation of bleomycin. A Southwest oncology Group study.
July 1976, Cancer,
E J Tilchen, and T Fleming, and G Mills, and N Oishi, and J D Bonnett, and R B Natale, and G Harker, and C A Coltman
Phase II evaluation of recombinant gamma-interferon in patients with advanced pancreatic carcinoma: a Southwest Oncology Group study.
December 1990, Journal of biological response modifiers,
E J Tilchen, and T Fleming, and G Mills, and N Oishi, and J D Bonnett, and R B Natale, and G Harker, and C A Coltman
Phase II evaluation of piroxantrone in renal cell carcinoma. A Southwest Oncology Group Study.
July 1992, Investigational new drugs,
E J Tilchen, and T Fleming, and G Mills, and N Oishi, and J D Bonnett, and R B Natale, and G Harker, and C A Coltman
Phase II evaluation of amonafide in renal cell carcinoma. A Southwest Oncology Group study.
November 1991, Investigational new drugs,
E J Tilchen, and T Fleming, and G Mills, and N Oishi, and J D Bonnett, and R B Natale, and G Harker, and C A Coltman
Phase II evaluation of esorubicin (4'deoxydoxorubicin) in pancreatic adenocarcinoma: a Southwest Oncology Group study.
February 1990, Investigational new drugs,
Copied contents to your clipboard!